Drug Delivery Systems in the Development of Novel Strategies for Glioblastoma Treatment

Glioblastoma multiforme (GBM) is a grade IV glioma considered the most fatal cancer of the central nervous system (CNS), with less than a 5% survival rate after five years. The tumor heterogeneity, the high infiltrative behavior of its cells, and the blood–brain barrier (BBB) that limits the access...

Descripción completa

Detalles Bibliográficos
Autores principales: El Kheir, Wiam, Marcos, Bernard, Virgilio, Nick, Paquette, Benoit, Faucheux, Nathalie, Lauzon, Marc-Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227363/
https://www.ncbi.nlm.nih.gov/pubmed/35745762
http://dx.doi.org/10.3390/pharmaceutics14061189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227363/
https://www.ncbi.nlm.nih.gov/pubmed/35745762
http://dx.doi.org/10.3390/pharmaceutics14061189

Ejemplares similares